422 related articles for article (PubMed ID: 15365966)
1. Allograft rejection and glomerular basement membrane antibodies in Alport's syndrome.
Charytan D; Torre A; Khurana M; Nicastri A; Stillman IE; Kalluri R
J Nephrol; 2004; 17(3):431-5. PubMed ID: 15365966
[TBL] [Abstract][Full Text] [Related]
2. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen.
Wang XP; Fogo AB; Colon S; Giannico G; Abul-Ezz SR; Miner JH; Borza DB
J Am Soc Nephrol; 2005 Dec; 16(12):3563-71. PubMed ID: 16236801
[TBL] [Abstract][Full Text] [Related]
3. Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Relationship of familial nephritis and Goodpasture antigens to novel collagen chains and type IV collagen.
Kleppel MM; Kashtan C; Santi PA; Wieslander J; Michael AF
Lab Invest; 1989 Sep; 61(3):278-89. PubMed ID: 2671490
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of the target antigens of anti-glomerular basement membrane antibody disease.
Borza DB; Hudson BG
Springer Semin Immunopathol; 2003 May; 24(4):345-61. PubMed ID: 12778332
[TBL] [Abstract][Full Text] [Related]
5. The non-collagenous domains of the alpha 3 and 4 chains of type IV collagen and their relationship to the Goodpasture antigen.
Savige JA; Gallicchio M
Clin Exp Immunol; 1991 Jun; 84(3):454-8. PubMed ID: 2044225
[TBL] [Abstract][Full Text] [Related]
6. Linear glomerular IgG fixation in renal allografts: incidence and significance in Alport's syndrome.
Quérin S; Noël LH; Grünfeld JP; Droz D; Mahieu P; Berger J; Kreis H
Clin Nephrol; 1986 Mar; 25(3):134-40. PubMed ID: 3514017
[TBL] [Abstract][Full Text] [Related]
7. Identification of alpha3, alpha4, and alpha5 chains of type IV collagen as alloantigens for Alport posttransplant anti-glomerular basement membrane antibodies.
Kalluri R; Torre A; Shield CF; Zamborsky ED; Werner MC; Suchin E; Wolf G; Helmchen UM; van den Heuvel LP; Grossman R; Aradhye S; Neilson EG
Transplantation; 2000 Feb; 69(4):679-83. PubMed ID: 10708133
[TBL] [Abstract][Full Text] [Related]
8. Circulating anti-glomerular basement membrane autoantibodies against α3(IV)NC1 undetectable by commercially available enzyme-linked immunosorbent assays.
Jia XY; Qu Z; Cui Z; Yang R; Zhao J; Zhao MH
Nephrology (Carlton); 2012 Feb; 17(2):160-6. PubMed ID: 21854504
[TBL] [Abstract][Full Text] [Related]
9. [Glomerulonephritis by glomerular anti-basement membrane antibodies after renal transplantation].
Noel LH; Bobrie G; Pochet JM; Pirson Y; Goldman M; Moulonguet-Doleris L; Farge D; Déchelette E; Grunfeld JP
Nephrologie; 1989; 10(3):113-5. PubMed ID: 2691906
[TBL] [Abstract][Full Text] [Related]
10. Kidney transplantation in Alport's syndrome: long-term outcome and allograft anti-GBM nephritis.
Göbel J; Olbricht CJ; Offner G; Helmchen U; Repp H; Koch KM; Frei U
Clin Nephrol; 1992 Dec; 38(6):299-304. PubMed ID: 1468159
[TBL] [Abstract][Full Text] [Related]
11. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.
Pedchenko V; Bondar O; Fogo AB; Vanacore R; Voziyan P; Kitching AR; Wieslander J; Kashtan C; Borza DB; Neilson EG; Wilson CB; Hudson BG
N Engl J Med; 2010 Jul; 363(4):343-54. PubMed ID: 20660402
[TBL] [Abstract][Full Text] [Related]
12. Anti-glomerular and anti-tubular basement membrane nephritis in a renal allograft recipient with Alport's syndrome.
Diaz JI; Valenzuela R; Gephardt G; Novick A; Tubbs RR
Arch Pathol Lab Med; 1994 Jul; 118(7):728-31. PubMed ID: 8024409
[TBL] [Abstract][Full Text] [Related]
13. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
[TBL] [Abstract][Full Text] [Related]
14. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
Brainwood D; Kashtan C; Gubler MC; Turner AN
Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
[TBL] [Abstract][Full Text] [Related]
15. Anti-glomerular basement membrane antibody-mediated nephritis complicating transplantation in a patient with Alport's syndrome.
Fleming SJ; Savage CO; McWilliam LJ; Pickering SJ; Ralston AJ; Johnson RW; Ackrill P
Transplantation; 1988 Dec; 46(6):857-9. PubMed ID: 3061081
[TBL] [Abstract][Full Text] [Related]
16. The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target.
vd Heuvel LP; Schröder CH; Savage CO; Menzel D; Assmann KJ; Monnens LA; Veerkamp JH
Pediatr Nephrol; 1989 Oct; 3(4):406-13. PubMed ID: 2642109
[TBL] [Abstract][Full Text] [Related]
17. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
Charytan D; MacDonald B; Sugimoto H; Pastan S; Staton G; Hennigar R; Kalluri R
Am J Kidney Dis; 2005 Apr; 45(4):743-8. PubMed ID: 15806477
[TBL] [Abstract][Full Text] [Related]
18. A single autoantigen in Goodpasture's syndrome identified by a monoclonal antibody to human glomerular basement membrane.
Pusey CD; Dash A; Kershaw MJ; Morgan A; Reilly A; Rees AJ; Lockwood CM
Lab Invest; 1987 Jan; 56(1):23-31. PubMed ID: 3540450
[TBL] [Abstract][Full Text] [Related]
19. High affinity of anti-GBM antibodies from Goodpasture and transplanted Alport patients to alpha3(IV)NC1 collagen.
Rutgers A; Meyers KE; Canziani G; Kalluri R; Lin J; Madaio MP
Kidney Int; 2000 Jul; 58(1):115-22. PubMed ID: 10886555
[TBL] [Abstract][Full Text] [Related]
20. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat.
Joosten SA; van Dixhoorn MG; Borrias MC; Benediktsson H; van Veelen PA; van Kooten C; Paul LC
Am J Pathol; 2002 Apr; 160(4):1301-10. PubMed ID: 11943715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
